About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Decides to put its BioElixia Cosmetics Brand up for Sale

February 25, 2015

Click here to read more

Post navigation

Phosphagenics Appoints Dr Ross Murdoch as Chief Executive Officer

Appendix 4E Preliminary Final Financial Report

Related Posts

Oxymorphone Patch Program Update

May 14, 2015

Phosphagenics Arbitration Award Issued

November 12, 2018

Placement to Advance Phase III Clinical Trial

August 28, 2023August 28, 2023

Recent Posts

US & EU Patent Allowances for CBD Soft-Gel Formulation
December 3, 2025
Research report | RaaS Watchlist: Waking the Sleeping Giant
August 26, 2025
Media | Avecho featured on 9 News
June 23, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.